Agilent Technologies has selected Fluor Corporation to expand its oligonucleotide therapeutics manufacturing facility in Colorado, USA. The unit will include state-of-the-art engineering enhancements such as advanced automation, water reduction strategies and solvent capturing to optimize cost and construction.
Construction is underway with completion expected by 2026.
(Source: Business Wire)
Texas/USA – Fluor Corporation has recently announced that its Advanced Technologies & Life Sciences business was selected by Agilent Technologies to expand its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado, just north of Denver. Fluor is supporting engineering and procurement as part of the project. The total project value is 725 million dollars.
“Speed to market is essential in the pharmaceutical industry,” said Juan Hernández, president of Fluor’s Advanced Technologies & Life Sciences business. “We will incorporate state-of-the-art engineering enhancements such as advanced automation, water reduction strategies and solvent capturing to optimize cost and construction. This enables us to fast-track the project so that Agilent can meet its global customers’ needs by getting products to market faster.”
Stay up to Date
Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability. The completed facility will provide for the synthesis, purification and lyophilization of Agilent’s custom nucleic acids therapeutics, also known as oligonucleotides or oligos.
Oligos are short deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules that serve as the active pharmaceutical ingredients for drugs targeting a growing number of diseases, including cancer, cardiovascular disease, and rare and infectious diseases. Construction is underway with completion expected by 2026.
(ID:49201634)
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
:quality(80)/p7i.vogel.de/wcms/17/8c/178cc63f59d73daf39e6fb18e0d4e60c/0115571482.jpeg "The complex shape of an origami crane that was restored using heat after being flattened. (Source: ©2023, Shota Ando)")
:quality(80)/p7i.vogel.de/wcms/23/a4/23a4e263443b01902ddc72a6d6f2b6e8/0115478975.jpeg "The new micrometric photovoltaic cells have remarkable characteristics, including an extremely small size and significantly reduced shadowing. (Source: free licensed)")
:quality(80)/p7i.vogel.de/wcms/85/45/85450f92aa743200a1e6e5170efd9804/0115476536.jpeg "A mature Megasyllis nipponica with a developing female stolon. (Source: The University of Tokyo)")
:quality(80)/p7i.vogel.de/wcms/f2/9b/f29bc701c6a2217230adb071a82b79ff/0115467633.jpeg "The authors recommend that the research community makes evidence comparable and actionable. (Source: Pixabay)")
:quality(80)/p7i.vogel.de/wcms/08/64/08641b24ed132cb587042d78e04024cc/0115589760.jpeg "The software app will also report average and minimum / maximum values of the measured flow. (Source: Testa Analytical Solutions )")
:quality(80)/p7i.vogel.de/wcms/b2/6e/b26eb1b2fbc53665c88cf7b13ce09c1c/0115369745.jpeg "Combo-One Viscometer/DRI dual detector as a standalone unit and as part of a multi detector GPC/SEC system. (Source:Testa Analytical)")
:quality(80)/p7i.vogel.de/wcms/53/9e/539e36b296df4f2ca47436a41def6df5/0115271768.jpeg "High performance Mirage 2D barcode reader and Individual Access PCR plate. (Source: Ziath )")
:quality(80)/p7i.vogel.de/wcms/4b/12/4b1218864cf0c524070bc136b39b8f11/0115169067.jpeg "Shimadzu’s new AGX-V2 series universal testing machine (UTM). (Source: Shimadzu )")
:quality(80)/p7i.vogel.de/wcms/bb/d4/bbd4f91011115df56d019066f00c8c50/0115588579.jpeg "Monomers recovered from the reaction. (Source: Tobin Marks/Northwestern University)")
:quality(80)/p7i.vogel.de/wcms/2b/d7/2bd7dc4ce2996a2008e2199065a3b45e/0115467622.jpeg "The paper highlights the interplay between the trend of climate warming and the fluctuations in local temperature. (Source: Pixabay)")
:quality(80)/p7i.vogel.de/wcms/c9/74/c974b9d8b55db6d6b83da8d9ecdcaa44/0115335335.jpeg "Photosynthesis is the scientific term for the process in which plants convert – or “fix” – CO2 into the sugars they use for growth and metabolism. (Source: free licensed)")
:quality(80)/p7i.vogel.de/wcms/d9/aa/d9aa26db96f4400b4e0f1671ba642e06/0115335298.jpeg "The Antarctic ice sheet is the largest block of ice on earth, containing over 30 million cubic kilometers of water. (Source: free licensed)")
:quality(80)/p7i.vogel.de/wcms/91/ed/91edb8954cba60a3cb81403d12a271f2/0115471629.jpeg "Eating ten percent more UPFs is associated with a 23 percent higher risk of head and neck cancer. (Source: frei lizenziert)")
:quality(80)/p7i.vogel.de/wcms/59/3e/593e991d44a385b47355e69eb0b73d85/0115203958.jpeg "Seaweed attached to a line. (Source: DTU)")
:quality(80)/p7i.vogel.de/wcms/bc/5a/bc5a4177c6429a27f884d0b765c75354/0114979969.jpeg "Red meat is popular, accessible and palatable – and its place in our diet has deep cultural roots. (Source: free licensed)")
:quality(80)/p7i.vogel.de/wcms/77/40/774068d69aa4ff6dcc6f29ef252fd94f/0114387548.jpeg "Sushi is generally safe to eat, but some bacteria in sushi, sashimi and cold-smoked fish products can pose a risk to people who eat such foods frequently, especially people with weak immune systems, children and the elderly. (Source: Idun Haugan, Norwegian University of Science and Technology)")
:quality(80)/p7i.vogel.de/wcms/93/bb/93bb1c82ef523ce1c73ae3d50165f072/0115494310.jpeg "AI evaluations of patient tissues were better at predicting the future course of a patient’s disease than evaluations performed by expert pathologists. (Source: Pixabay)")
:quality(80)/p7i.vogel.de/wcms/2b/07/2b077a88abd686f7e3bc978c2a71b8f7/0115469964.jpeg "The new study examined spore response of three different strains of C. diff to three clinical in-use concentrations of sodium hypochlorite. (Source: free licensed)")
:quality(80)/p7i.vogel.de/wcms/51/5a/515a024800b23e8ac593c7481d382282/0115452535.jpeg "Researchers at ETH Zurich have developed an AI model that helps to find suitable molecular sites for the development of new active substances. (Source: frei lizenziert)")
:quality(80)/p7i.vogel.de/wcms/c0/e9/c0e93cbcfe148e3da8c052f2e055b2ee/0115425062.jpeg "Sudden cardiac death is a major public health problem responsible for approximately one in five fatalities in Europe. (Source: Pixabay)")
:quality(80)/images.vogel.de/vogelonline/bdb/1710600/1710675/original.jpg "Discover how to set yourself up for success when performing balance-based density determination of solids such as jewelry and precious metals. (Mettler Toledo)")
:quality(80)/images.vogel.de/vogelonline/bdb/1682500/1682579/original.jpg "The new XPR Analytical balance redesigned to meet the needs of laboratory technicians of working fast and lean. (Mettler Toledo)")
:quality(80)/images.vogel.de/vogelonline/bdb/1677000/1677080/original.jpg "Enhance your weighing accuracy, comfort and productivity with the redesigned XPR Analytical balance. (Mettler Toledo)")
:quality(80)/p7i.vogel.de/wcms/c1/1b/c11b62e20d7a419337b0c6bfb602939c/0110326363.jpeg "Official opening of Evonik’s new GMP facility in Hanau, Germany. (Source: Evonik)")
:quality(80)/p7i.vogel.de/wcms/29/ec/29ec582c3232dbada4a0d13444bae7c0/0110655319.jpeg "The total investment into the commercial-scale lipid facility amounts to 220 million dollars. (Source: Evonik)")